1/90
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
A condition has been hypothesized to be based on the balanced relationship between 5-HT, NE and DA neurotransmitters.
Depression
Example of antidepressant drugs
TCAs (Tricyclic antidepressants)
[SNRIs(Serotonin and Norepinephrine Reuptake Inhibitors),
NSRIs (Norepinephrine/Serotonin Reuptake Inhibitors)],
SSRIs (Selective Serotonin Reuptake Inhibitors),
MAOIs (Monoamine Oxidase Inhibitors),
5HT2 (Serotonin receptor) Antagonist/SRM (Serotonin Reuptake Modulators)
Serotonin deficiency results to
anxiety,
panic,
phobia,
obsessive compulsions
Norepinephrine deficiency results to
decreased concentration,
decreased working memory,
decreased information processing fatigue
Dopamine deficiency results to
cognitive slowing,
hypersomnia,
anhedonia
Deficiency in dopamine and norepinephrine results to
decreased attention,
psychomotor retardation
Deficiency in serotonin and dopamine results to
food craving bulimia
Deficiency in serotonin, norepinephrine and dopamine results to
depressed mood
MOA options of antidepressants:
Agonize 5HT receptors,
Agonize NE receptors,
Block 5HT reuptake,
Block NE reuptake,
Block metabolism by MAO, Or any combination
These agents target a transporter protein: SERT, NET, and DAT
TCAs (SNRIs/NSRIs),
SSRIs (Selective Serotonin Reuptake Inhibitors),
NDRI (Norepinephrine/Dopamine Reuptake Inhibitor), and
SARI (Serotonin-2 Antagonist and Reuptake Inhibitors)
MOA TCAs:
blocks transporter_____ preventing inactivation of NTs, allowing NTs to function
proteins
MOA TCAs:
increased levels of _____, _____, and _____ relieves the signs of NT deficiency — antidepressant activity
5-HT (Serotonin), NE (Norepinephrine), DA (Dopamine)
SNRIs stands for
Selective Norepinephrine Reuptake Inhibitors
NSRIs stands for
Norepinephrine/Serotonin Reuptake Inhibitors
MOA SNRIs:
SNRI - selectively blocks _____
NET (norepinephrine transporter)
MOA NSRI:
NSRI - blocks NET and SERT (binding is dependent on _____ potency ratio)
NE:5HT (norepinephrine:serotonin)
TCAs are known to produce _____ like phenothiazines
"anti-HAM" effect
anti-HAM effect
anti-H1 (sedation),
anti-𝛼1 (orthostatic hypotension),
anti-M1 (dry mouth, constipation, blurred vision, urinary retention)
SAR TCA (SNRI and NSRI):
2° N is essential for _____ selectivity
SNRI
SAR TCA (SNRI and NSRI):
C3-X = _____ activity and affinity for NET & SERT
increases
SAR TCA (SNRI and NSRI):
B-ring side chain must be _____ long ending with an amine, branching side chain decreases affinity for NET & SERT
3 Carbons
SAR TCA (SNRI and NSRI):
Replacement of Ring N with propylene =
max potency
SAR TCA (SNRI and NSRI):
C10-C11 double bond = SAR TCA (SNRI and NSRI):
increase activity
SAR TCA (SNRI and NSRI):
_____-replacement in C10-C11 leads to an E/Z mixture resulting to preferential NET/SERT binding
O
METABOLISM TCA (SNRI and NSRI):
N-demethylation (SNRI = inactivation, NSRI = leads to NET inhibitors),
Aromatic hydroxylation (Atomoxetine, Duloxetine), CYP 2D6 hydroxylation (SNRI at C10; Clomipramine at C8),
CYP 2D6 demethylation (Clomipramine, Venlfaxine, Doxepin),
Glucuronidation
Dibenzazepines TCAs suffix
"-pramine"
Dibenzazepine TCA drug:
SNRI agent (2° amine)
Desipramine
Dibenzazepine TCA drug:
NSRI prototype drug (3° amine)
Imipramine
Dibenzazepine TCA drug:
NSRI agent (3° amine; Cl attachment at A3)
Clomipramine
Dibenzocycloheptadiene TCAs suffix
"-trptyline" (except Doxepin)
Dibenzocycloheptadiene TCA drug:
SNRI Agent; has N5-C12 double bond
Nortriptyline
Dibenzocycloheptadiene TCA drug:
SNRI Agent has C10-11 double bond
Protriptyline
Dibenzocycloheptadiene TCA drug:
NSRI Agent has a propylene moiety in the B-ring
Amitriptyline
Dibenzocycloheptadiene TCA drug:
NSRI Agent (E/Z isomers)
Doxepin
Doxepin E selectively inhibits
NET (Norepinephrine Transporter)
Doxepin Z selectively inhibits
SER (Serotonin)
Non-TCA SNRIs / NSRIs drug:
SNRI Agent; R-enantiomer is more active
Atomoxetine
Non-TCA SNRIs / NSRIs drug:
NSRI agents
Duloxetine,
Milnacipran,
Venlafaxine
SSRIs stands for
Selective Serotonin Reuptake Inhibitors
SAR SSRI:
Electronegative (-X) 4-substitution = essential for _____ and _____ for SERT
selectivity and affinity
SAR SSRI:
SSRI _____ significantly affects SERT selectivity
stereochemistry
MOA SSRI:
inhibits _____with high affinity and selectivity for SERT
SERT (Serotonin Transporter)
METABOLISM SSRI:
highly metabolized in the liver by CYP isozymes (especially CYP 2D6),
N-demethylation for N-methyl SSRIs,
MAO and Glucuronidation (Sertraline)
SSRI drug:
S-isomer is more active
Escitalopram
SSRI drug:
R-isomer; metabolite of Escitalopram
Citalopram
SSRI drug:
E-isomer is essential for SERT inhibition
Fluvoxamine
SSRI drug:
R-isomer more potent; S-isomer higher affinity for SERT
Fluoxetine (aka Happy Pill)
SSRI drug:
(-)-3S,4R-isomer is more active for SERT inhibition
Paroxetine
SSRI drug:
1S,4S-isomer is more active for SERT inhibition
Sertraline
MAOIs stands for
Monoamine Oxidase Inhibitors
MAO is an enzyme responsible for deamination of
amines
5-HT is a substrate for MAO-_____
A
Epinephrine, NE, and DA are substrates for MAO-_____ and MAO-_____
A and B
MAOIs may result in _____ (severe headache, tachycardia, diaphoresis, hyperpyrexia) when combined with sympathomimetics or tyramine-containing food.
hypertensive crisis
SAR MAOI:
some has similar structure with _____
amphetamine
SAR MAOI:
presence of electron-withdrawing groups =
increase potency
MOA MAOI:
inhibits metabolism of NE, 5-HT and DA =
increasing conc. in the brain
METABOLISM MAOI:
Oxidation and N-acetylation
MAOI drug:
reversible inhibitor of MAO-A antidepressant w/o hypertensive crisis
Moclobemide
MAOI drug:
resembles amphetamine with 𝛼-methyl condensing with β-carbon
Tranylcypromine
MAOI drug:
irreversible inhibitor of the enzyme
Phenelzine
MAOI drug:
selective irreversible inhibitor of MAO-B
Selegiline
SARIs stands for
Serotonin-2 Antagonist and Receptor Inhibitor
SRMs stands for
Serotonin Reuptake Modulators
SAR SARI/SRM:
All agents are _____ derivatives
phenylpiperazine
MOA SARI/SRM:
antagonizes _____ receptors and/or selectively inhibits SERT
5-HT2
MOA SARI/SRM (Trazodone):
_____ at 5-HT2A receptor = blocks excitation, hypnotic effects
antagonist
MOA SARI/SRM (Vilazodone):
partial _____ at 5-HT1A receptor postsynaptic releases of 5-HT
agonist
MOA SARI/SRM (Vortioxetine):
_____ at 5-HT1A receptor and SERT inhibitor
agonist
MOA SARI/SRM (Aripiprazole):
_____ at 5-HT2A receptor, and partial agonist at 5-HT1A receptor
antagonist
SARI/SRM drug:
5-HT1A agonist and SERT inhibitor
Vortioxetine
SARI/SRM drug:
with phenylpiperazine ring 5-HT2A antagonist
Trazodone
SARI/SRM drug:
partial 5-HT1A agonist
Vilazodone
NDRI stands for
Norepinephrine/Dopamine Reuptake Inhibitor
_____ is a unique compound acting on monoamine receptors useful in the management of depression and smoking cessation
Bupropion
MOA NDRI:
selective inhibition of DAT (dopmine transporter) and NET (norepinephrine transporter) =
increasing NE (norepinephrine)
T or F: MOA NDRI:
induces release of DA and NE
T
METABOLISM NDRI:
CYP 2B6 alkyl hydroxylation resulting to hemiketal forms and reduction resulting to theo and erythro hydrobupropion isomers and hemiketal
NaSSA stands for
Alpha-2-Noradrenrgic/Selective Serotonin Antidepressants
is single representative of NaSSA that has a complex mechanism of action
Mirtazapine
MOA NaSSA:
blocks presynaptic 𝛂2-adrenergic and 5-HT receptors (may lead to orthostatic hypotension) =
increasing NE and 5-HT levels.
MOA NaSSA:
selectively antagonizes _____ and _____ (may lead to sedation)
5-HT2 and 5HT3
METABOLISM NaSSA:
CYP3A4: N-demethylation and N-oxidation,
CYP 2D6: aromatic hydroxylation
TCA Pharmacophore rings responsible for antidepressants activity
Rings A and C
T or F: TCAs are more prescribed than SSRIs
F
Methylxanthines:
Of caffeine, theophylline, and theobromine, which has moderate effect?
Theobromine
Methylxanthines:
Most potent in CNS Stimulation, Respiratory Stimulation, and Skeletal Muscle Stimulation
Caffeine
Methylxanthines:
Most potent in Diuresis, Coronary Dilation, and Cardiac Stimulation
Theophylline
Methylxanthines:
1,3,7-Trimethylxanthine
Caffeine
Methylxanthines:
1,3-Dimethylxanthine
Theophylline
Methylxanthines:
3,7-Dimethyxanthines
Theobromine